WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine

BMC Microbiology

Volumn 8, Issue , 2008, Pages

  He, Fang ^a   Ho, Yuenfern ^a   Yu, Li ^a   Kwang, Jimmy ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; LIVE H5N1 VACCINE; UNCLASSIFIED DRUG; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; INFLUENZA VIRUS HEMAGGLUTININ; LUCIFERASE; VIRUS ANTIBODY;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AVIAN INFLUENZA; BACULOVIRUS; CHICKEN; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; INSECT CELL; NONHUMAN; VACCINATION; VACCINE PRODUCTION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; WHITE SPOT SYNDROME VIRUS; ANIMAL; ANIMAL MODEL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; IMMEDIATE EARLY GENE; IMMUNOLOGY; LUNG; METABOLISM; PROMOTER REGION; THYMUS; VIRUS GENE;

CYTOMEGALOVIRUS; GALLUS GALLUS; HEXAPODA; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SHRIMP WHITE SPOT SYNDROME VIRUS;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CELL LINE; CHICKENS; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION, VIRAL; GENES, IMMEDIATE-EARLY; GENES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNOHISTOCHEMISTRY; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; LUCIFERASES; LUNG; MODELS, ANIMAL; PROMOTER REGIONS, GENETIC; THYMUS GLAND; WHITE SPOT SYNDROME VIRUS 1;

EID: 61449177116     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-8-238     Document Type: Article

References (33)

1. Influenza: emergence and control. AS Lipatov EA Govorkova RJ Webby H Ozaki M Peiris Y Guan L Poon RG Webster, J Virol 2004 78 17 8951 8959 15308692 (Pubitemid 39096507)
2. Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine. WG Laver RG Webster, Postgrad Med J 1976 52 608 373 378 785428
3. Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use. A Safdar MM Cox, Expert Opin Investig Drugs 2007 16 7 927 934 17594180 (Pubitemid 47074153)
4. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. J Crawford B Wilkinson A Vosnesensky G Smith M Garcia H Stone ML Perdue, Vaccine 1999 17 18 2265 2274 10403594 (Pubitemid 29225678)
5. Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years. DE Swayne ML Perdue JR Beck M Garcia DL Suarez, Vet Microbiol 2000 74 12 165 172 10799788 (Pubitemid 30224654)
6. Complete genome sequence of the shrimp white spot bacilliform virus. F Yang J He X Lin Q Li D Pan X Zhang X Xu, J Virol 2001 75 23 11811 11820 11689662 (Pubitemid 33063272)
7. The white spot syndrome virus DNA genome sequence. MC van Hulten J Witteveldt S Peters N Kloosterboer R Tarchini M Fiers H Sandbrink RK Lankhorst JM Vlak, Virology 2001 286 1 7 22 11448154 (Pubitemid 32675461)
8. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. DG Yang YC Chung YK Lai CW Lai HJ Liu YC Hu, Mol Ther 2007 15 5 989 996 17375072 (Pubitemid 46621658)
9. Microarray and RT-PCR screening for white spot syndrome virus immediate-early genes in cycloheximide-treated shrimp. WJ Liu YS Chang CH Wang GH Kou CF Lo, Virology 2005 334 2 327 341 15780883 (Pubitemid 40386967)
10. Baculovirus-mediated promoter assay and transcriptional analysis of white spot syndrome virus orf427 gene. L Lu J Kwang, virology Journal 2005 2 71 16115322 (Pubitemid 41323984)
11. The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. FX Bosch M Orlich HD Klenk R Rott, Virology 1979 95 1 197 207 442540 (Pubitemid 9171792)
12. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Y Kawaoka RG Webster, Proc Natl Acad Sci USA 1988 85 2 324 328 2829180
13. Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. L Lu L Yu J Kwang, Biochem Biophys Res Commun 2007 358 2 404 409 17499217 (Pubitemid 46778910)
14. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. L Pieroni D Maione N La Monica, Hum Gene Ther 2001 12 8 871 881 11387053 (Pubitemid 32681852)
15. In vitro and in vivo gene delivery by recombinant baculoviruses. H Tani CK Limn CC Yap M Onishi M Nozaki Y Nishimune N Okahashi Y Kitagawa R Watanabe R Mochizuki, J Virol 2003 77 18 9799 9808 12941888 (Pubitemid 37122060)
16. A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G protein. JT Mangor SA Monsma MC Johnson GW Blissard, J Virol 2001 75 6 2544 2556 11222677 (Pubitemid 32185017)
17. Glycosylation is not required for the fusion activity of the G protein of vesicular stomatitis virus in insect cells. MJ Bailey DA McLeod CY Kang DH Bishop, Virology 1989 169 2 323 331 2650461 (Pubitemid 19105916)
18. Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Q He S Velumani Q Du CW Lim FK Ng R Donis J Kwang, Clin Vaccine Immunol 2007 14 5 617 623 17344345
19. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum. DJ King, Avian Dis 1991 35 3 505 514 1835374
20. Novel baculovirus DNA elements strongly stimulate activities of exogenous and endogenous promoters. HR Lo CC Chou TY Wu JP Yuen YC Chao, J Biol Chem 2002 277 7 5256 5264 11741907
21. Baculovirus-mediated gene expression in chicken primary cells. W Ping J Ge S Li H Zhou K Wang Y Feng Z Lou, Avian Dis 2006 50 1 59 63 16617983
22. Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus. S Wang L Fang H Fan Y Jiang Y Pan R Luo Q Zhao H Chen S Xiao, Vaccine 2007 25 49 8220 8227 17980465 (Pubitemid 350087390)
23. Efficient gene delivery into mammalian cells mediated by a recombinant baculovirus containing a whispovirus ie1 promoter, a novel shuttle promoter between insect cells and mammalian cells. H Gao Y Wang N Li WP Peng Y Sun GZ Tong HJ Qiu, J Biotechnol 2007 131 2 138 143 17640755 (Pubitemid 47187507)
24. The thymus: maestro of the immune system. JF Miller, Bioessays 1994 16 7 509 513 7945280 (Pubitemid 2110960)
25. The thymus and its role in immunity. JF Miller, Chem Immunol 1990 49 51 68 2190586
26. Introduction to poultry vaccines and immunity. JM Sharma, Adv Vet Med 1999 41 481 494 9890037
27. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JJ Treanor GM Schiff FG Hayden RC Brady CM Hay AL Meyer J Holden-Wiltse H Liang A Gilbert M Cox, Jama 2007 297 14 1577 1582 17426277 (Pubitemid 46588371)
28. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. JJ Treanor GM Schiff RB Couch TR Cate RC Brady CM Hay M Wolff D She MM Cox, J Infect Dis 2006 193 9 1223 1228 16586358
29. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. JJ Treanor BE Wilkinson F Masseoud J Hu-Primmer R Battaglia D O'Brien M Wolff G Rabinovich W Blackwelder JM Katz, Vaccine 2001 19 1314 1732 1737 11166898 (Pubitemid 32175735)
30. Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic. A Takada N Kuboki K Okazaki A Ninomiya H Tanaka H Ozaki S Itamura H Nishimura M Enami M Tashiro, J Virol 1999 73 10 8303 8307 10482580 (Pubitemid 29441691)
31. Characterization of ORF89 a latency-related gene of white spot syndrome virus. MS Hossain S Khadijah J Kwang, Virology 2004 325 1 106 115 15231390 (Pubitemid 38844774)
32. A basic laboratory manual for the small-scale production and testing of I-2 Newcastle disease vaccine. SE Grimes, RAP Publication 2002 136
33. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. T Rowe RA Abernathy J Hu-Primmer WW Thompson X Lu W Lim K Fukuda NJ Cox JM Katz, J Clin Microbiol 1999 37 4 937 943 10074505 (Pubitemid 29140593)